Pricing Log in Create free account

Cabaletta Bio, Inc. (CABA) vs Evommune Inc. (EVMN)

Cabaletta Bio, Inc. and Evommune Inc. are both Biotechnology companies. Cabaletta Bio, Inc. is the larger, with a market value of $280.4M against $241.3M — 1.2× the size. Across the 10 metrics below, Cabaletta Bio, Inc. leads on 5 and Evommune Inc. on 5.

Valuation

Metric CABA EVMN Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.93 0.87 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (120.77%) (165.86%) (32.88%)
Free cash flow yield (78.96%) (31.07%) (23.13%)

Profitability

Metric CABA EVMN Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (93.20%) (141.99%) (51.96%)
Return on assets (75.36%) (62.71%) (46.06%)
Return on invested capital 0.00% (82.46%) 0.00%

Growth

Metric CABA EVMN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 10.26% 75.23% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CABA EVMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.79 11.68 4.97
Net debt to EBITDA 0.84 1.87 1.01

Dividend

Metric CABA EVMN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CABA EVMN Biotechnology median
Market cap 280.44m 241.34m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack